Total Payments
$20,184
2024 Payments
$219.42
Companies
67
Transactions
1,444
Medicare Patients
2,718
Medicare Billing
$186,477
Payment Breakdown by Category
Food & Beverage$20,154 (99.9%)
Education$29.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,154 | 1,443 | 99.9% |
| Education | $29.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,761 | 217 | $0 (2023) |
| Novo Nordisk Inc | $2,310 | 178 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,934 | 109 | $0 (2023) |
| Lilly USA, LLC | $1,406 | 129 | $0 (2023) |
| AbbVie Inc. | $1,253 | 100 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,131 | 71 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,080 | 73 | $0 (2022) |
| Gilead Sciences, Inc. | $1,077 | 60 | $0 (2023) |
| Allergan, Inc. | $773.65 | 81 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $753.70 | 69 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.42 | 4 | ZOLL Respicardia, Inc. ($118.18) |
| 2023 | $2,078 | 141 | GlaxoSmithKline, LLC. ($487.39) |
| 2022 | $2,663 | 166 | GlaxoSmithKline, LLC. ($476.70) |
| 2021 | $2,991 | 194 | Novo Nordisk Inc ($429.54) |
| 2020 | $2,986 | 193 | GlaxoSmithKline, LLC. ($396.84) |
| 2019 | $3,750 | 262 | Novo Nordisk Inc ($534.03) |
| 2018 | $3,122 | 269 | GlaxoSmithKline, LLC. ($447.57) |
| 2017 | $2,372 | 215 | AstraZeneca Pharmaceuticals LP ($426.34) |
All Payment Transactions
1,444 individual payment records from CMS Open Payments — Page 1 of 58
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $58.75 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $80.29 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $59.43 | General |
| Category: Respiratory | ||||||
| 08/09/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Vascular | ||||||
| 09/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.41 | General |
| 09/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Neuromodulation | ||||||
| 09/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardio-renal | ||||||
| 09/26/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 09/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Biological | ||||||
| 09/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Gastroenterology | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 08/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: NEUROLOGY | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 704 | 791 | $83,987 | $50,517 |
| 2022 | 13 | 876 | 1,008 | $82,209 | $59,127 |
| 2021 | 10 | 626 | 755 | $58,268 | $40,822 |
| 2020 | 7 | 512 | 650 | $52,801 | $36,011 |
Total Patients
2,718
Total Services
3,204
Medicare Billing
$186,477
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $21,597 | $15,657 | 72.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 157 | $26,561 | $13,042 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 217 | $24,090 | $12,730 | 52.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,068 | $2,345 | 76.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,559 | $2,185 | 61.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $1,848 | $1,832 | 99.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 94 | 94 | $1,832 | $1,795 | 97.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 25 | 25 | $628.60 | $626.90 | 99.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 15 | $473.00 | $142.80 | 30.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 12 | $170.00 | $100.80 | 59.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 28 | $160.00 | $61.60 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $16,130 | $15,924 | 98.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 202 | $23,916 | $15,168 | 63.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 304 | $26,115 | $15,111 | 57.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 21 | 21 | $3,905 | $3,551 | 91.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $3,427 | $3,209 | 93.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 98 | 98 | $2,040 | $1,887 | 92.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 78 | 78 | $1,608 | $1,476 | 91.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $2,307 | $1,253 | 54.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 27 | 27 | $778.62 | $704.13 | 90.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 12 | $716.15 | $496.38 | 69.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 67 | 72 | $687.00 | $160.98 | 23.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $235.01 | $121.09 | 51.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 23 | 23 | $345.00 | $65.37 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 195 | 277 | $21,595 | $12,481 | 57.8% |
About Dr. Amy Easterling, D.O
Dr. Amy Easterling, D.O is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1881897270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Easterling, D.O has received a total of $20,184 in payments from pharmaceutical and medical device companies, with $219.42 received in 2024. These payments were reported across 1,444 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($20,154).
As a Medicare-enrolled provider, Easterling has provided services to 2,718 Medicare beneficiaries, totaling 3,204 services with total Medicare billing of $186,477. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 06/06/2007
- Last Updated 09/12/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881897270
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,326
- JARDIANCE (Drug) $1,148
- FARXIGA (Drug) $999.29
- Ozempic (Drug) $784.57
- VRAYLAR (Drug) $566.32
- TRULICITY (Drug) $500.28
- SHINGRIX (Biological) $463.84
- XIFAXAN (Drug) $444.17
- Saxenda (Drug) $443.24
- Victoza (Drug) $415.11
- UBRELVY (Drug) $414.82
- LINZESS (Drug) $402.37
- ANORO (Drug) $379.87
- TOUJEO (Drug) $377.69
- Trintellix (Drug) $358.78
- SOLIQUA 100/33 (Biological) $344.22
- Livalo (Drug) $310.87
- TRINTELLIX (Drug) $289.85
- Stendra (Drug) $274.82
- XARELTO (Drug) $270.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Family Medicine $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
Family Medicine $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Family Medicine $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Family Medicine $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Family Medicine $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768
Family Medicine $32,768